Latch Bio
Bioinformatics in the Browser
The CRISPR community is facing a tsunami of data but a dearth of computational tools required for their analyses. By empowering the researcher, Latch is helping remove a significant bottleneck that is currently slowing down the CRISPR research cycle, enabling the discovery of new therapies.
Explore LUX COMPANIES
industries
Engineering Electronics
Advancing Human Health
Increasing Productivity Efficiency
milestones
Lux investment: 2018
founders
Daniel Hawkins
Lux Partners
industries
Securing Life Environment
milestones
Lux investment: 2016
founders
Andrea Carcano, PhD
Moreno Carullo, PhD
Lux Partners
industries
Advancing Human Health
milestones
Lux investment: 2018
founders
Nancy Yu
Onno Faber
Lux Partners
industries
Biology Biochemistry
Advancing Human Health
milestones
Lux investment: 2018
founders
Akhila Kosaraju
Kaja Wasik
Stephane Castel
Lux Partners
industries
Advancing Human Health
Enabling Human Creativity Free Expression
milestones
Lux investment: 2019
founders
Wayne Mackey, PhD
Jay Fuller, PhD
Lux Partners
